Fiore AE, et al. (2011). Antiviral agents for the treatment and chemoprophylaxis of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 60(1): 1–25.
Nichol KL, et al. (2007). Effectiveness of influenza vaccine in the community-dwelling elderly. New England Journal of Medicine, 357(14): 1373–1381.
Zaman K, et al. (2008). Effectiveness of maternal influenza
immunization in mothers and infants. New England Journal of Medicine, 359(15): 1555–1564.
Eick AA, et al. (2011). Maternal influenza vaccination and effect on influenza virus infection in young infants.
Archives of Pediatrics and Adolescent Medicine, 165(2): 104–111.
Leyer GJ, et al. (2009). Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics, 124(2): e172–e179.
Centers for Disease Control and Prevention (2006). CDC Health Alert: CDC Recommends Against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States During the 2005–06 Influenza Season. Available online: http://www.cdc.gov/flu/han011406.htm.
Cooper NJ, et al. (2003). Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-analyses of randomised controlled trials. BMJ, 326(7401): 1235.
Other Works Consulted
American Academy of Pediatrics (2011). Recommendations for prevention and control of influenza in children, 2011–2012. Pediatrics, 128(4): 813–825.
U.S. Centers for Disease Control and Prevention (2011). Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)—United States, April 2009–August 2010. Morbidity and Mortality Weekly Report, 60(35): 1193–1196.